Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature
Severe mucormycosis is a fatal disease rarely complicating chronic lymphoproliferative disorders. We present a fulminant and fatal case of a 74-year-old Caucasian woman suffering from CLL treated with second-generation BTK inhibitor zanubrutinib. After a first septic episode a month prior, originati...
Main Authors: | Giuseppe Maggioni, Marny Fedrigo, Andrea Visentin, Elisa Carturan, Valeria Ruocco, Livio Trentin, Mauro Alaibac, Annalisa Angelini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/9/599 |
Similar Items
-
Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after COVID-19 vaccination, complicated with COVID-19 and mucormycosis: a case report
by: Hamed Amirifard, et al.
Published: (2024-05-01) -
Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis
by: Malene Risum, et al.
Published: (2020-11-01) -
The study of DNA methylation anomalies in chronic lymphocytic leukaemia
by: Roy, NBA
Published: (2011) -
Treatment of relapsed/refractory chronic lymphocytic leukemia with Zanubrutinib after progressing on other BTK inhibitors
by: Nkolika Nwankwo, et al.
Published: (2024-01-01) -
Covid-19-Associated Mucormycosis: Histopathology of the Deadly Fungal Infection
by: Nidhi Anand, et al.
Published: (2024-04-01)